Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Immuno-Oncology Congress 2024

Primary IO refractory cancers

GDF-15: A cytokine involved in IO escape?

Date

12 Dec 2024

Session

Primary IO refractory cancers

Topics

Immunotherapy

Tumour Site

Non-Small Cell Lung Cancer;  Genitourinary Cancers

Presenters

Elena Garralda

Authors

E. Garralda

Author affiliations

  • Vall d'Hebron University Hospital, Barcelona/ES

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.